6/17, 3:23 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Danaher Corp

Danaher buying Aldevron for $9.6 billion

Danaher Corp. announced on Thursday that it will purchase biotech company Aldevron in an all-cash deal worth $9.6 billion.

"This acquisition will expand our capabilities into the important field of genomic medicine and help us support our customers and their critical mission to bring more life-saving therapies and vaccines to market faster," Danaher CEO Rainer Blair said in the press release.

The transaction is subject to all customary regulatory and shareholder approval.

Breaking the News / MD